2008


1. Reymond JL
Substrate arrays for fluorescence-based enzyme fingerprinting and high-throughput screening.
Ann. N Y Acad. Sci. 1130 (2008) 12-20

2. Planque S, Nishiyama Y, Taguchi H, Salas M, Hanson C, Paul S.
Catalytic antibodies to HIV: physiological role and potential clinical utility.
Autoimmun. Rev. 7 (2008) 473-479

3. Taguchi H, Planque S, Nishiyama Y, Szabo P, Weksler ME, Friedland RP, Paul S.
Catalytic antibodies to amyloid beta peptide in defense against Alzheimer disease.
Autoimmun. Rev. 7 (2008) 391-397

4. Kim DS, Lee SH, Kim JS, Lee SC, Kwon MH, Kim YS.
Generation of humanized anti-DNA hydrolyzing catalytic antibodies by complementarity determining region grafting.
Biochem. Biophys. Res. Commun. 379 (2008) 314-318

5. Yamaji H, Manabe T, Watakabe K, Muraoka M, Fujii I & Fukuda H
Production of functional antibody Fab fragment by recombinant insect cells.
Biochem. Eng. J. 41 (2008) 203-209

6. Krasnorutskii MA, Buneva VN, Nevinsky GA.
Antibodies against DNA hydrolyze DNA and RNA.
Biochemistry (Mosc.) 73 (2008) 1242-1253

7. Kit YY, Starykovych MA, Richter VA, Stoika RS.
Detection and characterization of IgG- and sIgA-Abzymes capable of hydrolyzing histone H1.
Biochemistry (Mosc.) 73 (2008) 950-956

8. Krasnorutskii MA, Buneva VN & Nevinsky GA
Immunization of rabbits with DNase I produces polyclonal antibodies with DNase and RNase activities.
Biochemistry (Mosc.) 2008 (2008) 233-242

9. Krasnorutskii MA, Buneva VN & Nevinsky GA
Antibodies against pancreatic ribonuclease A hydrolyze RNA and DNA.
Biochemistry (Mosc.) 20 (2008) 1031-1040

10. Tanaka F, Hu Y, Sutton J, Asawapornmongkol L, Fuller R, Olson AJ, Barbas CF 3rd, Lerner RA.
Selection of phage-displayed peptides that bind to a particular ligand-bound antibody.
Bioorg. Med. Chem. 16 (2008) 5926-5931

11. Tsumuraya T & Fujii I
Molecular basis for transition-state stabilization in catalytic antibodies.
Bull. Chem. Soc. Japan 81 (2008) 1039-1052

12. Smith BM.
Catalytic methods for the destruction of chemical warfare agents under ambient conditions.
Chem. Soc. Rev. 37 (2008) 470-478

13. Marti S, Andres J, Moliner V, Silla E, Tunon I, Bertran J.
Theoretical study of catalytic efficiency of a Diels-Alderase catalytic antibody: an indirect effect produced during the maturation process.
Chemistry 14 (2008) 596-602

14. Wojcik T, Kie-Kononowicz K.
Catalytic activity of certain antibodies as a potential tool for drug synthesis and for directed prodrug therapies.
Curr. Med. Chem. 15 (2008) 1606-1615

15. Nieri P, Donadio E, Rossi S, Adinolfi B, Podesta A.
Antibodies for therapeutic uses and the evolution of biotechniques.
Curr. Med. Chem. 16 (2008) 753-779

16. Smirnov IV, Vorobiev II, Friboulet A, Avalle B, Thomas D, Knorre VD, Gabibov AG, Ponomarenko NA.
The antiidiotypic approach to obtaining a proteolytic antibody.
Dokl. Biochem. Biophys. 420 (2008) 105-107

17. Cao JS, Guo CH, Wang XQ, He CY & Zhang PT
DNA-hydrolysing activity of immunoglobulin G from bulk bovine colostrum.
Food Agr. Immunol. 19 (2008) 107-116

18. Liu JQ, Wulff G.
Functional mimicry of carboxypeptidase A by a combination of transition state stabilization and a defined orientation of catalytic moieties in molecularly imprinted polymers.
J. Am. Chem. Soc. 120 (2008) 8044-8054

19. Pan Y, Gao D, Zhan CG.
Modeling the catalysis of anti-cocaine catalytic antibody: competing reaction pathways and free energy barriers.
J. Am. Chem. Soc. 130 (2008) 5140-5149

20. Debler EW, Muller R, Hilvert D, Wilson IA.
Conformational isomerism can limit antibody catalysis.
J. Biol. Chem. 283 (2008) 16554-16560

21. Hifumi E, Morihara F, Hatiuchi K, Okuda T, Nishizono A, Uda T.
Catalytic features and eradication ability of antibody light-chain UA15-L against Helicobacter pylori.
J. Biol. Chem. 283 (2008) 899-907

22. Taguchi H, Planque S, Nishiyama Y, Symersky J, Boivin S, Szabo P, Friedland RP, Ramsland PA, Edmundson AB, Weksler ME & Paul S
Autoantibody-catalyzed hydrolysis of amyloid beta peptide.
J. Biol. Chem. 283 (2008) 4714-4722

23. Taguchi H, Planque S, Sapparapu G, Boivin S, Hara M, Nishiyama Y, Paul S.
Exceptional amyloid beta peptide hydrolyzing activity of nonphysiological immunoglobulin variable domain scaffolds.
J. Biol. Chem. 283 (2008) 36724-36733

24. Wootla B, Dasgupta S, Dimitrov JD, Bayry J, Lévesque H, Borg JY, Borel-Derlon A, Rao DN, Friboulet A, Kaveri SV, Lacroix-Desmazes S.
Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia.
J. Immunol. 180 (2008) 7714-7720

25. Belogurov AA Jr, Kurkova IN, Friboulet A, Thomas D, Misikov VK, Zakharova MY, Suchkov SV, Kotov SV, Alehin AI, Avalle B, Souslova EA, Morse HC 3rd, Gabibov AG, Ponomarenko NA.
Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.
J. Immunol. 180 (2008) 1258-1267

26. Wootla B, Nicoletti A, Patey N, Dimitrov JD, Legendre C, Christophe OD, Friboulet A, Kaveri SV, Lacroix-Desmazes S, Thaunat O.
Hydrolysis of coagulation factors by circulating IgG is associated with a reduced risk for chronic allograft nephropathy in renal transplanted patients.
J. Immunol. 180 (2008) 8455-8460

27. Karlberg T, Hansson MD, Yengo RK, Johansson R, Thorvaldsen HO, Ferreira GC, Hansson M, Al-Karadaghi S.
Porphyrin binding and distortion and substrate specificity in the ferrochelatase reaction: the role of active site residues.
J. Mol. Biol. 378 (2008) 1074-1083

28. Krasnorutskii MA, Buneva VN, Nevinsky GA.
Antibodies against RNA hydrolyze RNA and DNA.
J. Mol. Recognit. 21 (2008) 338-347

29. Huo R, Wei J, Xu J, Lv S, Zheng Q, Yan F, Su J, Fan J, Li J, Duan Y, Yu Y, Jin F, Sun W, Shi Y, Cong D, Li W, Yan G, Luo G.
Human catalytic antibody Se-scFv-B3 with high glutathione peroxidase activity.
J. Mol. Recognit. 21 (2008) 324-329

30. Krasnorutskii MA, Buneva VN, Nevinsky GA.
Immunization of rabbits with DNase I produces polyclonal antibodies with DNase and RNase activities.
J. Mol. Recognit. 21 (2008) 233-242

31. Alexandrova AN, Jorgensen WL.
Origin of the Activity Drop with the E50D Variant of Catalytic Antibody 34E4 for Kemp Elimination.
J. Phys. Chem. B 113 (2008) 497-504

32. Zheng F, Zhan CG.
Structure-and-mechanism-based design and discovery of therapeutics for cocaine overdose and addiction.
Org. Biomol. Chem. 6 (2008) 835-843

33. Mayorov AV, Amara N, Chang JY, Moss JA, Hixon MS, Ruiz DI, Meijler MM, Zorrilla EP, Janda KD.
Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice.
Proc. Natl. Acad. Sci. USA 105 (2008) 17487-17492

34. Verdino P, Aldag C, Hilvert D & Wilson IA
Closely related antibody receptors exploit fundamentally different strategies for steroid recognition.
Proc. Natl. Acad. Sci. USA 105 (2008) 11725-11730

35. Mu Y, Song D, Li Y, Zhang HQ, Li W, Luo GM, Jin QH.
Selection of phage antibodies with GPX activity by combination of phage displayed antibody library with chemical modification and their characterization using a surface plasmon resonance biosensor.
Talanta 66 (2008) 181-187

36. Pal'tsev MA, Suchkov SV.
"Functionality" of antibodies: clinical implications.
Ter. Arkh. 80 (2008) 68-75




Retour